Scantox looks forward to attend the Anglo Nordic Life Science event in London again in 2024!
Over the past year, Scantox has been working intentionally to round out our service offerings, striving to become a complete, full-service IND-enabling tox lab. While our capabilities encompass many areas, we are particularly proud of our expertise in safety assessment, general toxicology, and specialty areas.
Additionally, Scantox’s commitment to quality and innovation has propelled our growth and reputation within the industry. Through strategic investments in state-of-the-art facilities, the latest technology, and highly skilled scientific personnel, Scantox has positioned itself as a trusted partner for drug development and regulatory submissions. Our dedication to staying abreast of evolving regulatory requirements and industry standards further solidifies our standing as a premier CRO.
Meet:
 |
 |
| Steve Lovick Business Development Director UK & Ireland |
Olivia Merinder Larsson Business Development Manager |